Texas 2025 - 89th Regular

Texas House Bill HB1791 Latest Draft

Bill / Introduced Version Filed 01/08/2025

Download
.pdf .doc .html
                            89R4878 CJD-F
 By: Bucy H.B. No. 1791




 A BILL TO BE ENTITLED
 AN ACT
 relating to the duties of a prescriber issuing an opioid
 prescription to treat acute pain.
 BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
 SECTION 1.  The heading to Section 481.07636, Health and
 Safety Code, is amended to read as follows:
 Sec. 481.07636.  PRESCRIBING OPIOID FOR ACUTE PAIN;
 PRESCRIPTION LIMITS.
 SECTION 2.  Section 481.07636, Health and Safety Code, is
 amended by adding Subsection (b-1) and amending Subsection (c) to
 read as follows:
 (b-1)  A prescriber who prescribes an opioid to a person for
 the treatment of acute pain shall also prescribe to the person an
 opioid antagonist.
 (c)  Subsections  [Subsection] (b) and (b-1) do [does] not
 apply to a prescription for an opioid approved by the United States
 Food and Drug Administration for the treatment of substance
 addiction that is issued by a practitioner for the treatment of
 substance addiction.
 SECTION 3.  Subchapter C, Chapter 481, Health and Safety
 Code, is amended by adding Section 481.07637 to read as follows:
 Sec. 481.07637.  ALTERNATIVE TREATMENTS FOR ACUTE PAIN. (a)
 In this section, "acute pain" has the meaning assigned by Section
 481.07636.
 (b)  When issuing an opioid prescription for acute pain, a
 prescriber shall also consider referring or prescribing any of the
 following pain management services to a patient, based on the
 prescriber's clinical judgment and the availability of the
 treatment:
 (1)  chiropractic treatment;
 (2)  physical therapies;
 (3)  occupational therapies;
 (4)  physical medicine and rehabilitation; or
 (5)  osteopathic manipulation.
 (c)  This section does not require that all of the treatments
 under Subsection (b) be exhausted before the patient may receive a
 prescription for an opioid.
 SECTION 4.  Section 481.003(a), Health and Safety Code, is
 amended to read as follows:
 (a)  The director may adopt rules to administer and enforce
 this chapter, other than Sections 481.074, 481.075, 481.0755,
 481.0756, 481.076, 481.0761, 481.0762, 481.0763, 481.07635,
 481.07636, 481.07637, 481.0764, 481.0765, 481.0766, 481.0767,
 481.0768, and 481.0769.  The board may adopt rules to administer
 Sections 481.074, 481.075, 481.0755, 481.0756, 481.076, 481.0761,
 481.0762, 481.0763, 481.07635, 481.07636, 481.07637, 481.0764,
 481.0765, 481.0766, 481.0767, 481.0768, and 481.0769.
 SECTION 5.  Section 554.051(a-1), Occupations Code, is
 amended to read as follows:
 (a-1)  The board may adopt rules to administer Sections
 481.074, 481.075, 481.0755, 481.0756, 481.076, 481.0761, 481.0762,
 481.0763, 481.07635, 481.07636, 481.07637, 481.0764, 481.0765,
 481.0766, 481.0767, 481.0768, and 481.0769, Health and Safety Code.
 SECTION 6.  Section 565.003, Occupations Code, as amended by
 Chapters 1105 (H.B. 2174) and 1166 (H.B. 3284), Acts of the 86th
 Legislature, Regular Session, 2019, is reenacted to read as
 follows:
 Sec. 565.003.  ADDITIONAL GROUNDS FOR DISCIPLINE REGARDING
 APPLICANT FOR OR HOLDER OF NONRESIDENT PHARMACY LICENSE.  Unless
 compliance would violate the pharmacy or drug statutes or rules in
 the state in which the pharmacy is located, the board may discipline
 an applicant for or the holder of a nonresident pharmacy license if
 the board finds that the applicant or license holder has failed to
 comply with:
 (1)  Subchapter C, Chapter 481, Health and Safety Code;
 (2)  Texas substitution requirements regarding:
 (A)  the practitioner's directions concerning
 generic substitution;
 (B)  the patient's right to refuse generic
 substitution; or
 (C)  notification to the patient of the patient's
 right to refuse substitution;
 (3)  any board rule relating to providing drug
 information to the patient or the patient's agent in written form or
 by telephone; or
 (4)  any board rule adopted under Section 554.051(a)
 and determined by the board to be applicable under Section
 554.051(b).
 SECTION 7.  This Act takes effect September 1, 2025.